Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study
NCT01479400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152
Last updated 2011-11-24
Summary
The primary aim of this prospective study is to evaluate the effect of antipsychotics on infant development especially neurobehavioral development which evaluated by the Bayley-III when mothers are treated with antipsychotics throughout their pregnancy.
Conditions
Sponsors & Collaborators
-
Central South University
lead OTHER
Eligibility
- Min Age
- 1 Day
- Max Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2010-12-31
- Completion
- 2011-05-31
Countries
- China
Study Locations
More Related Trials
-
Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia
NCT01222793 ·Status: COMPLETED
-
Developmental Psychopathology and the Gene-environment Interaction
NCT04489069 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
NCT00654576 ·Status: COMPLETED ·Phase: PHASE4
-
Resting State Electroencephalogram for Psychotic Disorders
NCT05065489 ·Status: UNKNOWN
-
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
NCT04218981 ·Status: COMPLETED ·Phase: NA
-
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents
NCT04370730 ·Status: RECRUITING ·Phase: NA
-
Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia
NCT04972227 ·Status: COMPLETED ·Phase: PHASE1
-
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
NCT03149107 ·Status: TERMINATED ·Phase: PHASE3
-
Extrapyramidal Side-Effects in Antipsychotic Drug Therapeutics
NCT02366897 ·Status: COMPLETED ·Phase: NA
-
Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series
NCT02199704 ·Status: COMPLETED ·Phase: NA
-
Patientheque in Patients With a Psychosis .
NCT05340348 ·Status: RECRUITING ·Phase: NA
-
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study
NCT05872555 ·Status: ACTIVE_NOT_RECRUITING
-
Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis
NCT05796401 ·Status: RECRUITING ·Phase: PHASE3
-
Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
NCT03790085 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study
NCT03651674 ·Status: UNKNOWN ·Phase: NA
-
Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group
NCT03965598 ·Status: UNKNOWN
-
Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia
NCT07102069 ·Status: COMPLETED
-
Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia
NCT04291469 ·Status: UNKNOWN ·Phase: NA
-
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
NCT00937755 ·Status: COMPLETED
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Antipsychotic Induced Structural and Functional Brain Changes
NCT02435095 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Studies of the Pathogenesis of Schizophrenia
NCT00877552 ·Status: COMPLETED
-
Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia
NCT02964923 ·Status: UNKNOWN
-
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
NCT01720316 ·Status: COMPLETED ·Phase: PHASE2